🩺 How are advances in targeted therapy, immunotherapy, and biomarkers reshaping gastrointestinal cancer care?
In this latest review, Ahmed Maklad and Rafea Hakki explore the evolving treatment landscape across major gastrointestinal cancers, highlighting the shift toward biomarker-driven precision oncology.
From emerging therapeutic targets and antibody–drug conjugates to circulating tumor DNA (ctDNA) and personalized treatment strategies, the authors examine key developments and ongoing challenges, including disparities in access to testing and care.
🔗 Read the full review: touchoncology.com/gastrointestin…
#GICancer #GastrointestinalCancer #PrecisionOncology #Immunotherapy #Oncology
In this latest review, Ahmed Maklad and Rafea Hakki explore the evolving treatment landscape across major gastrointestinal cancers, highlighting the shift toward biomarker-driven precision oncology.
From emerging therapeutic targets and antibody–drug conjugates to circulating tumor DNA (ctDNA) and personalized treatment strategies, the authors examine key developments and ongoing challenges, including disparities in access to testing and care.
🔗 Read the full review: touchoncology.com/gastrointestin…
#GICancer #GastrointestinalCancer #PrecisionOncology #Immunotherapy #Oncology